Sponsor pipeline

Autolus Limited clinical trial pipeline

6 active trials 3 recruiting 7 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT07053800	Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus…	Lupus Nephritis	Recruiting	2026-08-24
NCT03628612	Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells	Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy	Enrolling by Invitation	2026-09-22
Phase 1/2
NCT04404660	A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory…	Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia	Active, Not Recruiting	2026-04-08
Phase 1
NCT06173518	A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or…	Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia	Recruiting	2026-10-09
NCT07139743	Obe-cel in Refractory Progressive Forms of Multiple Sclerosis	Progressive Multiple Sclerosis	Recruiting	2026-03-23
NCT06333483	Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus…	Systemic Lupus Erythematosus	Active, Not Recruiting	2026-07-31

Get alerts when Autolus Limited's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.